Our company was co-founded by leading pioneers in precision oncology and RAS targeting—to create novel therapies and combination regimens designed to comprehensively silence the RAS/MAPK pathway for the treatment of cancer.
Our leadership team and employees have broad and deep experience in company building and in oncology, including advancing therapeutic candidates from discovery research to clinical development, regulatory approval, and commercialization.
Senior Chemistry Advisor
Senior Crystallography Advisor
Senior Development Advisor
Senior ADME/PK Advisor
Senior Toxicology Advisor
Senior Medical Advisor
Senior Regulatory Affairs Advisor